Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 138.62 USD -3.23% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Glaukos Corp?
Write Note

Glaukos Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glaukos Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Glaukos Corp
NYSE:GKOS
Revenue
$446m
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
30%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

Glaukos Corp
Revenue Breakdown

Breakdown by Geography
Glaukos Corp

Total Revenue: 314.7m USD
100%
United States: 219.4m USD
69.7%
International: 95.3m USD
30.3%

Breakdown by Segments
Glaukos Corp

Total Revenue: 314.7m USD
100%
Represents The Glaucoma Product Category: 237m USD
75.3%
Represents The Corneal Health Product Category: 77.7m USD
24.7%

See Also

What is Glaukos Corp's Revenue?
Revenue
446m USD

Based on the financial report for Sep 30, 2024, Glaukos Corp's Revenue amounts to 446m USD.

What is Glaukos Corp's Revenue growth rate?
Revenue CAGR 10Y
30%

Over the last year, the Revenue growth was 47%. The average annual Revenue growth rates for Glaukos Corp have been 15% over the past three years , 15% over the past five years , and 30% over the past ten years .

Back to Top